-
公开(公告)号：KR1020160117015A
公开(公告)日：2016-10-10
申请号：KR1020150045560
申请日：2015-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K31/704 , A61K8/60 , A61Q19/00
CPC classification number: A61K31/704 , A61K8/60 , A61Q19/00
Abstract: 본발명은진세노사이드 Rg1을유효성분으로함유하고, 상기진세노사이드 Rg1은서리아신을억제하는것을특징으로하는피부외용제조성물에관한것이다. 본발명에따른피부외용제조성물은피부질환예방및 경감용또는피부보습용으로사용될수 있다. 이때, 상기피부질환은아토피또는건선을포함한다. 본발명의피부외용제조성물은서리아신이유발하는피부각질세포형성의이상현상을저지할수 있으며, 이에따라피부질환을예방또는경감할수 있고, 피부수분함유량을향상시킬수 있다.
-
公开(公告)号：KR1020130099930A
公开(公告)日：2013-09-06
申请号：KR1020137005744
申请日：2011-08-31
Applicant: (주)아모레퍼시픽
IPC: C07D487/04 , C07D403/04 , A61K31/519 , A61P29/00
CPC classification number: C07D487/04 , A61K31/519
Abstract: PURPOSE: A novel compound is provided to prevent or treat diseases mediated by a cannabinoid 1 receptor. CONSTITUTION: A compound of chemical formula 1 or a prodrug, an isomer, a pharmaceutically acceptable salt, a hydrate, or a solvate thereof is provided. A pharmaceutical composition contains the compound of chemical formula 1, the prodrug, the isomer, the pharmaceutically acceptable salt, the hydrate, or the solvate thereof. The pharmaceutical composition is used for preventing or treating diseases mediated by cannabinoid 1 receptor. The diseases medicated by cannabinoid 1 receptor are obesity.
Abstract translation: 目的：提供一种新型化合物，用于预防或治疗由大麻素1受体介导的疾病。 构成：提供化学式1化合物或其前体药物，异构体，药学上可接受的盐，水合物或溶剂合物。 药物组合物含有化学式1的化合物，前药，异构体，药学上可接受的盐，水合物或其溶剂化物。 药物组合物用于预防或治疗由大麻素1受体介导的疾病。 由大麻素1受体引起的疾病是肥胖。
-
公开(公告)号：KR102213922B1
公开(公告)日：2021-02-08
申请号：KR1020170083517
申请日：2017-06-30
Applicant: (주)아모레퍼시픽
Abstract: 섬유아세포및 콜라겐을혼합하여진피모사층을형성하는단계, 상기진피모사층위에각질형성세포를적용한후 배양하는단계, 그리고상기각질형성세포가적용된진피모사층을파이루베이트성분이제거된표피배양배지에서배양하는단계를포함하는인공피부제조방법을제공한다.
-
-
公开(公告)号：KR1020110028741A
公开(公告)日：2011-03-22
申请号：KR1020090086317
申请日：2009-09-14
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for improving exercise endurance capacity and recovery capability is provided to form a health food with the composition containing chito-oligosaccharide. CONSTITUTION: A composition for improving exercise endurance capacity and recovery capability contains chito-oligosaccharide as an active component. The chito-oligosaccharide increases the utilization coefficient of internal fat acid of a user and reduces the concentration of lactic acid in blood. The chito-oligosaccharide additionally increases the storage content of glycogen of the user.
Abstract translation: 目的：提供一种用于提高运动耐力和恢复能力的组合物，以形成含有低聚半乳糖的组合物的保健食品。 构成：用于提高运动耐力和恢复能力的组合物含有作为活性成分的低聚半乳糖。 氯低聚糖增加了使用者的内部脂肪酸的利用系数，降低了血液中乳酸的浓度。 氯低聚糖另外增加了使用者糖原的储存量。
-
Patent Agency Ranking
-
公开(公告)号：KR1020160118481A
公开(公告)日：2016-10-12
申请号：KR1020150046643
申请日：2015-04-02
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61K9/20 , A61K9/48 , A23L1/30
CPC classification number: A61K36/258
Abstract: 본발명은난소노화를개선하는인삼열매추출물에관한것으로, 보다상세하게는인삼열매성분이난포수를증가시켜난소노화를개선하는데효과가있는인삼열매추출물을함유하는조성물에관한것이다. 본발명의인삼열매추출물을유효성분으로함유하는조성물은노화에의한난포의고갈을억제함으로써, 조기폐경의예방및 폐경기지연에이용할수 있다.
-
公开(公告)号：KR1020130122569A
公开(公告)日：2013-11-07
申请号：KR1020130047359
申请日：2013-04-29
Applicant: (주)아모레퍼시픽
Abstract: The present invention relates to a composition containing collagen peptides for promoting skin regeneration after laser surgery. The composition according to the present invention activates skin cells (keratinocytes, fibroblasts) and increases cell migration. Especially, the composition is able to promote skin regeneration after laser surgery. Thus, the composition promotes skin recovery after laser surgery, increases skin elasticity, and minimizes moisture loss on skin, thereby treating erythema.
Abstract translation: 本发明涉及包含用于促进激光手术后皮肤再生的胶原肽的组合物。 根据本发明的组合物激活皮肤细胞（角质形成细胞，成纤维细胞）并增加细胞迁移。 特别地，组合物能够促进激光手术后的皮肤再生。 因此，组合物促进激光手术后的皮肤恢复，增加皮肤弹性，并最大限度地减少皮肤上的水分流失，从而治疗红斑。
-
-
公开(公告)号：KR101899094B1
公开(公告)日：2018-09-14
申请号：KR1020170018128
申请日：2017-02-09
Applicant: (주)아모레퍼시픽
Abstract: 본발명에따른실시예에의한모낭및 상기모낭에결합되는털을포함하는털 조직을배양하는마이크로플루이딕디바이스로서, 몸체, 상기몸체내의일측에형성되며, 내부에배지(培地) 및콜라겐젤이적어도일부채워질수 있는적어도하나의조직배양공간및 상기조직배양공간과연결되며, 상기몸체의일측을관통하는조직배양공간입구를포함하며, 상기모낭은상기조직배양공간내에위치하고, 상기털은상기조직배양공간입구를관통할수 있다.
-
-
-
-
-
-
-
-
-
Search Results
32
records
(took 0.02 seconds)
